News

Cantor Fitzgerald initiated coverage of Eli Lilly (LLY) with an Overweight rating and $975 price target Published first on ...
Cantor Fitzgerald analyst Carter Gould downgraded Amgen (AMGN) to Neutral from Overweight with a price target of $305, down ...
Cantor Fitzgerald trimmed its price target on Intel (NASDAQ:INTC) to $20 from $29 while maintaining a Neutral rating, ...